Medical technology company Optomed is a leading producer of handheld fundus cameras globally.

By integrating our software and Artificial Intelligence solutions with our cameras, we enable eye screening for everyone – wherever they are.

Optomed as an investment

Optomed is a research and development as well as sales driven medical technology company in expansion phase.

1.

Optomed is one of the leading players in the growing and transforming handheld fundus camera market.

2.

Future growth potential from expansion into new markets and end-customer segments.

3.

Provider of proprietary technology with targeted value propositions for different markets and healthcare systems.

4.

Asset-light organisation through outsourced production and distribution, with a well-defined sales strategy and extensive distribution network.

5.

Experienced management to promote the transformation of the fundus screening market.

Latest releases

Subscribe releases

Share Price
Nasdaq Helsinki Stock Exchange

Share Price
Nasdaq Helsinki Stock Exchange

Key figures 2020

Net sales 2020

13.0

EUR, million

Gross margin

68.8

%

Adjusted EBITDA

-0.7

EUR, million

Equity ratio

64.6

%